REPORT ID 10205

Global Irritable Bowel Syndrome Treatment Market Research Report 2017

Publish Date
16-Nov-17
Pages
109
Format
Electronic (PDF)

In this report, the global Irritable Bowel Syndrome Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Irritable Bowel Syndrome Treatment in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Irritable Bowel Syndrome Treatment market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Abbott Laboratories
    Synergy Pharmaceuticals, Inc.
    Sucampo Pharmaceuticals, Inc.
    Valeant Pharmaceuticals International, Inc.
    Ardelyx, Inc.
    Astellas Pharma Inc.
    Novartis AG
    GlaxoSmithKline plc.
    Ironwood Pharmaceuticals, Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Lubiprostone
    Linaclotide
    Eluxadoline
    Rifaximin
    Ramosetron Hydrochloride
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Home Care

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Irritable Bowel Syndrome Treatment Market Research Report 2017
1 Irritable Bowel Syndrome Treatment Market Overview
    1.1 Product Overview and Scope of Irritable Bowel Syndrome Treatment
    1.2 Irritable Bowel Syndrome Treatment Segment by Type (Product Category)
        1.2.1 Global Irritable Bowel Syndrome Treatment Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Irritable Bowel Syndrome Treatment Production Market Share by Type (Product Category) in 2016
        1.2.3 Lubiprostone
        1.2.4 Linaclotide
        1.2.5 Eluxadoline
        1.2.6 Rifaximin
        1.2.7 Ramosetron Hydrochloride
        1.2.8 Others
    1.3 Global Irritable Bowel Syndrome Treatment Segment by Application
        1.3.1 Irritable Bowel Syndrome Treatment Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Care
    1.4 Global Irritable Bowel Syndrome Treatment Market by Region (2012-2022)
        1.4.1 Global Irritable Bowel Syndrome Treatment Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Irritable Bowel Syndrome Treatment (2012-2022)
        1.5.1 Global Irritable Bowel Syndrome Treatment Revenue Status and Outlook (2012-2022)
        1.5.2 Global Irritable Bowel Syndrome Treatment Capacity, Production Status and Outlook (2012-2022)

2 Global Irritable Bowel Syndrome Treatment Market Competition by Manufacturers
    2.1 Global Irritable Bowel Syndrome Treatment Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Irritable Bowel Syndrome Treatment Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Irritable Bowel Syndrome Treatment Production and Share by Manufacturers (2012-2017)
    2.2 Global Irritable Bowel Syndrome Treatment Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Irritable Bowel Syndrome Treatment Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Irritable Bowel Syndrome Treatment Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Irritable Bowel Syndrome Treatment Market Competitive Situation and Trends
        2.5.1 Irritable Bowel Syndrome Treatment Market Concentration Rate
        2.5.2 Irritable Bowel Syndrome Treatment Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Irritable Bowel Syndrome Treatment Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Irritable Bowel Syndrome Treatment Capacity and Market Share by Region (2012-2017)
    3.2 Global Irritable Bowel Syndrome Treatment Production and Market Share by Region (2012-2017)
    3.3 Global Irritable Bowel Syndrome Treatment Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Irritable Bowel Syndrome Treatment Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Irritable Bowel Syndrome Treatment Consumption by Region (2012-2017)
    4.2 North America Irritable Bowel Syndrome Treatment Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Irritable Bowel Syndrome Treatment Production, Consumption, Export, Import (2012-2017)
    4.4 China Irritable Bowel Syndrome Treatment Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Irritable Bowel Syndrome Treatment Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Irritable Bowel Syndrome Treatment Production, Consumption, Export, Import (2012-2017)
    4.7 India Irritable Bowel Syndrome Treatment Production, Consumption, Export, Import (2012-2017)

5 Global Irritable Bowel Syndrome Treatment Production, Revenue (Value), Price Trend by Type
    5.1 Global Irritable Bowel Syndrome Treatment Production and Market Share by Type (2012-2017)
    5.2 Global Irritable Bowel Syndrome Treatment Revenue and Market Share by Type (2012-2017)
    5.3 Global Irritable Bowel Syndrome Treatment Price by Type (2012-2017)
    5.4 Global Irritable Bowel Syndrome Treatment Production Growth by Type (2012-2017)

6 Global Irritable Bowel Syndrome Treatment Market Analysis by Application
    6.1 Global Irritable Bowel Syndrome Treatment Consumption and Market Share by Application (2012-2017)
    6.2 Global Irritable Bowel Syndrome Treatment Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Irritable Bowel Syndrome Treatment Manufacturers Profiles/Analysis
    7.1 Abbott Laboratories
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Synergy Pharmaceuticals, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Synergy Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Sucampo Pharmaceuticals, Inc.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Sucampo Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Valeant Pharmaceuticals International, Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Valeant Pharmaceuticals International, Inc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Ardelyx, Inc.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Ardelyx, Inc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Astellas Pharma Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Astellas Pharma Inc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Novartis AG
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Novartis AG Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 GlaxoSmithKline plc.
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 GlaxoSmithKline plc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Ironwood Pharmaceuticals, Inc.
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Irritable Bowel Syndrome Treatment Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Ironwood Pharmaceuticals, Inc. Irritable Bowel Syndrome Treatment Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview

8 Irritable Bowel Syndrome Treatment Manufacturing Cost Analysis
    8.1 Irritable Bowel Syndrome Treatment Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Irritable Bowel Syndrome Treatment

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Irritable Bowel Syndrome Treatment Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Irritable Bowel Syndrome Treatment Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Irritable Bowel Syndrome Treatment Market Forecast (2017-2022)
    12.1 Global Irritable Bowel Syndrome Treatment Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Irritable Bowel Syndrome Treatment Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Irritable Bowel Syndrome Treatment Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Irritable Bowel Syndrome Treatment Price and Trend Forecast (2017-2022)
    12.2 Global Irritable Bowel Syndrome Treatment Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Irritable Bowel Syndrome Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Irritable Bowel Syndrome Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Irritable Bowel Syndrome Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Irritable Bowel Syndrome Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Irritable Bowel Syndrome Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Irritable Bowel Syndrome Treatment Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Irritable Bowel Syndrome Treatment Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Irritable Bowel Syndrome Treatment Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer